Impact of long-acting implantable LYR-210 corticosteroid matrices on quality of life of patients with chronic rhinosinusitis in the LANTERN study

Int Forum Allergy Rhinol. 2023 Sep;13(9):1821-1824. doi: 10.1002/alr.23139. Epub 2023 Feb 27.
No abstract available

Keywords: SNOT-22; chronic rhinosinusitis; quality of life; topical therapy for chronic rhinosinusitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Chronic Disease
  • Humans
  • Quality of Life
  • Rhinitis* / drug therapy
  • Sinusitis* / drug therapy

Substances

  • Adrenal Cortex Hormones